의사로서의 전문성, 진료의 기술과 더불어 인본주의의 마음을 최고로 하는 의사이고 싶습니다.
오전 ● ● ● ● ● 교대근무
오후 ● ● ● ● ● ●
▶ 치매 Dementia
알츠하이머병 및 치매환자의 이상행동/ 혈관성 경도 인지장애/ 인지재활
치매환자의 우울증/ 치매환자의 배뇨장애/ 말기치매
▶ 뇌졸중 Stroke
뇌졸중재활/ 뇌졸중환자의 행동 및 인지장애
한림대학교 의과대학원 석사
1997 한림대학교 강남성심병원 인턴수료
1998-2002 한림대학교 강동성심병원 신경과 전공의 수료
2003 삼성의료원 신경과 기억장애 클리닉 방문전임의
2003.8- 현재 보바스기념병원 신경과장
2008.7- 2010.12 성남시 노인보건센터 연구부장
2011.3- 2012.7 보바스기념병원 진료부장
2012.8- 2013.7 미국 버지니아주립대학교 신경과 연구교수
2013.8-현재 보바스기념병원 뇌건강센터장
2015.3-현재 성남시 노인보건센터장, 성남시 치매관리단장
[소속학회/단체]
2005- 현재 대한 신경과 학회 정회원, 보험위원
2007- 현재 대한 치매학회 정보위원
2008- 2010 대한 치매학회 보험간사
2009- 2010 대한 노인신경의학회 총무간사
2010- 2012 대한 치매학회 보험이사
2010- 현재 대한 노인신경의학회 보험이사
2010- 현재 대한 신경과학회 상대가치 위원회 부위원장
2011.3- 현재 대한 신경계질환우울증연구회 총무이사
2014.3- 현재 대한 치매학회 재무이사
2017.9- 현재 대한 인지중재학회 홍보이사
2018.2- 현재 성남시 중원구 치매안심센터장
2005 대한 치매학회 젊은 연구자상
2007 대한 치매학회 우수 논문상
2008 대한 치매학회 에자이 학술상
2012 노인신경의학회 우수 연구자상
2007.3-2015. 12 보건복지부 치매임상연구 주도 연구자
2015 대한 치매학회 우수 논문상
2018 보건복지부 장관표창
미국 버지니아주립대학교 신경과 연구교수
보바스기념병원 뇌건강센터장
성남시 노인보건센터장, 성남시 치매관리단장
대한 신경과 학회 정회원, 보험위원
대한 치매학회 정보위원
대한 치매학회 보험간사
대한 노인신경의학회 총무간사
대한 치매학회 보험이사
대한 노인신경의학회 보험이사
대한 신경과학회 상대가치 위원회 부위원장
대한 신경계질환우울증연구회 총무이사
대한 치매학회 재무이사
대한 인지중재학회 홍보이사
성남시 중원구 치매안심센터장
대한 치매학회 젊은 연구자상
대한 치매학회 우수 논문상
대한 치매학회 에자이 학술상
노인신경의학회 우수 연구자상
보건복지부 치매임상연구 주도 연구자
2006.3.1-2008.2.28 중등도에서 증증 알쯔하이머병 환자에서 도네페질(아리셉트정)의 인지 기능에 대한 유효성을 평가하기 위한 6개월 관찰 추적 시험[보바스기념병원]
2010.3.1-2014.12 기억성경도인지장애(MCI)에서 재가 및 그룹 인지훈련 프로그램의 유효성을 조사하기 위한 다기관, 무작위 배정 임상시험[보건복지가족부]
2013.2-현재 말기 알츠하이머병 환자에서의 도네페질 또는 메만틴 중단에 관한 연구 : 12주간의 다기관, 무작위 배정 연구[보건복지가족부]
2015.8-현재 고령 운전자 능력 평가 설문지에 대한 유용성 연구 및 인지기능과 운전 능력에 대한 연구[분당서울대병원/성남시]
2015.3-현재 한국형 노인형 운동프로그램의 치매 예방 효과와 효능 검증[성남시]
2015.6-현재 치료적 개입프로그램의 치매환자를 돌보는 보호자 부담감소 유효성 조사를 위한 다기관, 무작위배정 연구자 주도 임상연구[이화여자대학교]
2015.6-현재 한국형 치매예방 다중 영역 중재 프로그램 개발 한국보건산업진흥연구원
REPRESENTATIVE PUBLICATIONS(대표 편찬 경력)
HR Na. Diagnosis and Classification of normal pressure hydrocephalus. Clinical practice in dementia, Korean Dementia Society, 2007, 573-600
HR Na. Cognitive Rehabilitation in patients with neurologic disorders. Textbook of Neurology, Korean Neurology Association, 2012.
HR Na, Moon Ho Park. Screening test of dementia. Clinical practice in dementia, Korean Dementia Society, 2012.
HR Na, Carol Manning. Delirium in Clinical Geropsychology. p.549-562.AmericanPsychiatricAssociation, 2013
HR Na. Cognitive Rehabilitation in patients with neurologic disorders. Textbook of Neurology, Korean Neurology Association, 2017.
1. Age-Specific Cutoff Scores on a T1-Weighted Axial Medial Temporal-Lobe Atrophy Visual Rating Scale in Alzheimer's Disease Using Clinical Research Center for Dementia of South Korea Data. Choi GS, Kim GH, Choi JH, Hwang J, Kwon E, Lee SA, Kong KA, Kang HJ, Yoon B, Kim BC, Yang DW, Na DL, Kim EJ, Na HR, Han HJ, Lee JH, Kim JH, Lee KY, Park KH, Park KW, Kim S, Han SH, Kim SY, Yoon SJ, Moon SY, Youn YC, Choi SH, Jeong JH. J Clin Neurol. 2018Jul;14(3):275-282.
2. Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study. Yun Jeong Hong, Seong Hye Choi, Jee Hyang Jeong, Kyung Won Park, Hae Ri Na, J Alzheimers Dis. 2018;63(3):1035-1044.
3. Effects of Pelvic Floor Muscle Exercise on Urinary Incontinence in Elderly Women With Cognitive Impairment. Lee BA, Kim SJ, Choi DK, Kwon O, Na HR, Cho ST. Int Neurourol J .2017;21(4):295-301.
4. Genitourinary problems in the elderly in geriatric hospitals. ST Cho, HR Na. J Korean Med Assoc 2017; 60(7):536-541
5. Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom. Jung HB, Choi DK, Lee SH, Cho ST, Na HR, Park MH. Int Braz J Urol. 2017;43(2):256-263.
6. Association between Mitofusin 2 Gene Polymorphisms and Late-Onset Alzheimer's Disease in the Korean Population. Kim YJ, Park JK, Kang WS, Kim SK, Han C, Na HR, Park HJ, Kim JW, Kim YY, Park MH, Paik JW. Psychiatry Investig. 2017;14(1):81-85.
7. The effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer’s disease: A Multicenter, 24-week Prospective, Randomized, Open-label study (The Korean EXPECT study). Soo Jin Yoon, Seong Hye Choi, Hae Ri Na, Kyung-Won Park, Eun-Joo Kim, Hyun Jeong Han, MD, Jae-Hong Lee, Young Soo Shim, Duk L. Na. Geriatr Gerontol. 2017;17(3):494-499
8. Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific Region. Sabbagh M, Han S, Kim S, Na HR, Lee JH, Kandiah N, Phanthumchinda K, Suthisisang C, Senanarong V, Pai MC, Narilastri D, Sowani AM, Ampil E, Dash A. Dement Geriatr Cogn Dis Extra. 2016;6(3):382-395
9. Association of tripartite motif family-like 2 (TRIML2) polymorphisms with late-onset Alzheimer's disease risk in a Korean population. Kang WS, Park JK, Kim YJ, Cho AR, Park HJ, Kim SK, Paik JW, Lee KJ, Na HR, Kim YY, Lim HK, Jeong HG, Kim JW. Neurosci Lett. 2016Jul25;630:127-131.
10. Genetic association of STARD6 polymorphisms with Alzheimer's disease in a Korean population. Kim YJ, Paik JW, Kang WS, Kim SK, Lee KJ, Na HR, Park HJ, Kim JW, Lim HK, Park JK. J Neurol Sci. 2016Jul15;366:100-1.
11. Group and home-based cognitive intervention for patients with MCI: a randomized controlled trial. HR Na, JH Jeong, SH Choi, JE Kim, Duk L. Na, SW Seo, Juhee Chin, SA Park, EJ Kim, HJ Han, SH Han, SJ Yoon, JH Lee, KW Park, SY Moon, MH Park, MS Choi, IW Han, JH Lee, JS Lee, YS. Shim, JY Kim. Psychother Psychosom. 2016;85(4):198-207
12. Unstable Body Mass Index and Progression to Probable Alzheimer’s Disease Dementia in Patients with Amnestic Mild Cognitive Impairment. BS Ye, EY Jang, SY Kim, EJ Kim, SA Park, YH Lee, CH Hong, SH Choi, B Yoon, SJ Yoon, HR Na, JH Lee, JH Jeong, HJ Kim, DL Na SW Seo. J Alzheimers Dis 49 (2016) 483–491
13. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study. Kim S, Choi SH, Lee YM, Kim MJ, Kim YD, Kim JY, Park JH, Myung W, Na HR, Han HJ, Shim YS, Kim JH, Yoon SJ, Kim SY, Kim DK. Int Psychogeriatr.2015Jul27: 2069-77.
14. Urinary incontinence in Alzheimer's disease is associated with Clinical Dementia Rating-Sum of Boxes and Barthel Activities of Daily Living. Na HR, Park MH, Cho ST, Lee BC, Park S, Kim KH, Choi JB. Asia Pac Psychiatry.2015Mar;7(1):113-20.
15. Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer's disease patients: a CREDOS study. Park HK, Choi SH, Park SA, Kim HJ, Lee Y, Han SH, Kim EJ, Kim BC, Han HJ, Moon SY, Yang DW, Park KW, Park KH, Yoon B, Seo SW, Na DL, Na HR, Lee JH. JAl zheimers Dis.2015;44(2):661-73.
16. Factors Influencing Skin Tolerability to the Rivastigmine Patch in Patients with Alzheimer’s Disease. Hae Ri Na, Moon Ho Park, SangYun Kim, Dong Won Yang, Seong-Hye Choi, Hyun Duk Yang, Young Soon Yang, Hyun Jeong Han, Jung Seok Lee, Young-Chul Yoon, Seong-Ho Koh, Jung Eun Kim, Bon D. Ku, Hee-Jin Kim, Kyung Won Park, Eun-Joo Kim, Bora Yoon, Key Jung Park. Dement Neurocogn Disord 2015;14(1):31-38
17. Cognitive therapy combined with drug treatment in patients with Alzheimer`s disease: A neuropsychological and Positron Emission Tomography Investigation, a pilot study. HaeRi Na, Sang Yun Kim, Yu Kyeong Kim, Moon Ho Park, Sung Tae Cho, Woo Jung Kim. Dement Neurocogn Disord 2015;14(2):76-82
18. Urinary incontinence in patients with Alzheimer's disease: Relationship between symptom status and urodynamic diagnoses. Lee SH, Cho ST, Na HR, Ko SB, Park MH. IntJUrol.2014Jul;21(7):683-7.
19. Interaction of white matter hyperintensities (WMHs) and apolipoprotein E (APOE) genotypes on cognition in patients with amnestic mild cognitive impairment (aMCI). Yoon B, Shim YS, Cheong HK, Kim YD, Lee KO, Hong YJ, Oh YS, Na HR, Kim BC, Choi SH, Yang DW. Arch Gerontol Geriatr. 2013 Nov-Dec ;57(3):292-7.
20. Fantasies about stem cell therapy in chronic ischemic stroke patients. Kim YS, Chung DI, Choi H, Baek W, Kim HY, Heo SH, Chang DI, Na HR, Kim SH, Koh SH. StemCellsDev.2013Jan1;22(1):31-6.
21. Activities of Daily Living and Dementia.YoungSoon Yang · Hyun Duk Yang · Yun-Jung Hong · Jung Eun Kim · Moon-Ho Park · Hae Ri Na · Il-Woo Han · SangYun Kim.DementGeriatrCognDisord2012; 11(2):29.
22. Neurologic signs in relation to cognitive function in subcortical ischemic vascular dementia: a CREDOS (Clinical Research Center for Dementia of South Korea) study. Choi SH, Kim S, Han SH, Na DL, Kim DK, Cheong HK, Lee JH, Kim SY, Hong CH, Moon SY, Kwon JC, Kim JE, Jeong JH, Na HR, Cha KR, Seo SW, Shim YS, Lee JY, Park KW. NeurolSci.2012Aug;33(4):839-4
23. The Characteristics of Capgras Syndrome in Patients Diagnosed as Probable Alzheimer Disease. Il Mi Jang, Hakjae Roh,Moo Young Ahn, Young Soon Yang,Hae Ri Na, Sang Yun Kim. Soonchunhyang Medical Science. 2011; 17(2):72-74.
24. Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer Patients. Hyun Jeong Han, Byeong C. Kim, Jun-Young Lee, Seung-Ho Ryu, Hae Ri Na, Soo Jin Yoon, Hyun Young Park. DementGeriatrCognDisord2012;34:167–173
25. Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study. Choi SH, Park KW, Na DL, Han HJ, Kim EJ, Shim YS, Lee JH, Na, HR; Expect Study Group. Curr Med Res Opin. 2011 Jul; 27(7):1375-83.
26. Effects of lacunar infarctions on cognitive impairment in patients with cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lee JS, Choi JC, Kang SY, Kang JH, Na HR, Park JK. J Clin Neurol. 2011 Dec; 7(4):210-4
27. The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease. Neuropsychol Cogn. Baek MJ, Kim HJ, Ryu HJ, Lee SH, Han SH, Na HR, Chang Y, Chey JY, Kim S. Neuropsychol Dev Cogn B Aging.2011;12:1-16.
28. Validation Analysis of the Attention Questionnaire Scale. Kim S, Park MH, Han SH, Na HR, Cho S, Choi MS, Lee JH, Na DL, Kim JE, Park KW. JAl zheimersDis.2011;24:393-402
29. Neurologic signs in relation to cognitive function in subcortical ischemic vascular dementia: a CREDOS (Clinical Research Center for Dementia of South Korea) study. SeongHyeChoi, SangyunKim, Seol-HeuiHan, DukLNa,Doh-KwanKim, Hae-KwanCheong, Jae-HongLee, SeongYoonKim, ChangHyungHong, SoYoungMoon, JayCKwon, JungEunKim, JeeHJeong, HaeRiNa, KyungRyeolCha, SangWonSeo, YongSShim, Jun-YoungLee, KyungWonPark .Neurological Sciences, 2011;33(4):839-46.
30. Detecting amyloid-beta oligomers in Alzheimer patient's blood using multimer detection system. SeongAn, KuntaekLim, ByungsubLee, GwangJeKim, MinoKang, SeongminKang, YoungSoonYang, HaeRiNa, YoungChulYoun, SangYunKim. Alzheimer's and Dementia. 2010; 6(4):S518-S519.
31. Vascular risk factors and white matter lesions on extrapyramidal signs in Alzheimer’s disease. Moon Ho Park, Joo Young Min, Do-Young Kwon, Seung Hwan Lee, Hae Ri Na, Sung Tae Cho, Duk L. Na. Int Psychogeriatr. 2010;29:1-8.
32. A case of cardiac cephalalgia showing reversible coronary vasospasm on coronary angiogram.Yang Y, Jeong D, Jin DG, Jang IM, Jang Y, Na HR, Kim S. J Clin Neurol.2010;6:99-101.
33. Donepezil treatment in Alzheimer’s disease patients with and without cerebrovascular lesions: A preliminary report. Hae-Ri Na, SangYun Kim, Seong-Hye Choi, Dong-Won Yang, Hee-Joon Bae, Jung-Eun Kim, Mee-Young Park, Yong-Soo Shim, Byung-Kun Kim, Jae-Cheol Kwon, Bong-Goo Yoo, Byeong-Chae Kim, Jung-Seok Lee. Geriatr Gerontol Int 2010;11:90-7
34. Functional Assessment Staging (FAST) in Korean Patients with Alzheimer’s Disease, Hae Ri Na, SangYun Kim, YoungHee Chang, Moon Ho Park, Sung Tae Cho, IlWoo Han, Tae-You Kim, Sul-A Hwang. JAlzheimersDis.2010;22:151-8.
35. Study of the usefulness of the Korean story recall test in patients with Alzheimer's disease. MinJ .Baek, HyunJ. Kim, HuiJ.Ryu, SeungH.Lee, YoungS.Yang, HaeR.Na, SeolH.Han, SangyunKim. Alzheimer' sand Dementia. 2009;5(4)
36. Inappropriate sexual behaviors in patients with vascular dementia: Possible response to finasteride, HR Na, Joung Wook Lee, Seong Min Park, Seok Bum Ko, SangYun Kim, Sung Tae Cho. J Am Geriatr Soc. 2009;57:2161
37. Clinical Experience of the Transdermal Patch of Rivastigmine in Korean patients with Dementia; Preliminary study. Hae Ri Na, Hyun Seok Kang, Sang Seok Kim, Seol-Heui Han. Dement Neurocogn Disord 2009;8:61-6
38. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer’s disease. HR Na, Lee SH, Lee JS, Doody RS, Kim SY. Dement Geriatr Cogn Disord 2009;27:69-75 .
39. Effect of ApoE Genotype on Response to Donepezil in Patients with Alzheimer’s Disease. SH Choi, SY Kim, HR Na, BK Kim, DW Yang, JC. Kwon, MY Park. Dement Geriatr Cogn Disord2008;25:445–50
40. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease. Jung SM, Lee K, Lee JW, Namkoong H, Kim HK, Kim S, Na HR, Ha SA, Kim JR, Ko J, Kim JW. NeurosciLett.20089;436:153-7.
41. Absence of Association between Codon 129 and 219 Polymorphisms of the Prion Protein Gene and Vascular Dementia. BH Jeong, HR Na, JC Bae, KH Lee, YJ Lee, NH Kim, JH Song, RI. Carp, YS Kim. DementGeriatrCognDisord2007;24:86–90
42. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease. JW Lee, NK Hong, HK Kim, SH Kim, DW Hwang, HR Na, SA Ha, JR Kim, JW Kim. BMCNeurology2007;7:14